免疫系统
计算生物学
免疫疗法
癌症免疫疗法
保护
免疫检查点
计算机科学
生物
生物信息学
医学
免疫监视
免疫学
清脆的
癌症
纳米技术
先天免疫系统
基因组工程
核糖核酸
适体
多样性(控制论)
作者
Hulya Bayraktutan,Rafał J. Kopiasz,Amr Elsherbeny,Pratik Gurnani,Cameron Alexander
出处
期刊:Chemical Science
[Royal Society of Chemistry]
日期:2025-12-10
卷期号:17 (2): 850-879
被引量:1
摘要
The immune system is critical in safeguarding human health against a variety of external and internal threats, yet its dysregulation can lead to serious diseases such as autoimmune disorders and cancers. However, recent years have witnessed notable progress in immunotherapeutic interventions, including the development of novel modalities such as messenger RNA and DNA vaccines, immunotherapies using immune checkpoint inhibitors, and personalised dendritic cell vaccines. To optimise the delivery of these promising therapies, there is a growing interest in understanding how to target efficiently immune cells and immune-rich organs. Among the various delivery systems explored, synthetic polymers have emerged as versatile platforms, offering tuneable properties to modulate the immune system effectively. Poly(beta-amino esters) (PBAEs), characterised by their pH-dependent degradability and nanoparticle-forming capabilities, have gained significant attention as a promising delivery system in immunotherapy, immune-oncology, and vaccination. This review evaluates recent advances and applications of PBAEs in immunology. Beginning with an overview of synthetic methodologies, we cover their utilisation for nucleic acid, small molecule, and protein delivery, addressing therapeutic challenges associated with the immune system. We explore the diverse monomer chemistries employed in these applications and evaluate PBAEs in cutting-edge approaches such as mRNA and DNA vaccines, cancer immunotherapies, and immune cell reprogramming. By evaluating existing literature, this review aims to provide insights into the potential of PBAEs in immunotherapy while defining future directions for exploration in this rapidly evolving field.
科研通智能强力驱动
Strongly Powered by AbleSci AI